Giaccone G - Search Results

1

Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry.

Harada T, Lopez-Chavez A, Xi L, Raffeld M, Wang Y, Giaccone G. Harada T, et al. Among authors: giaccone g. Oncogene. 2011 Apr 14;30(15):1744-52. doi: 10.1038/onc.2010.545. Epub 2010 Dec 6. Oncogene. 2011. PMID: 21132006 Free PMC article.

2

Small cell lung cancer and topoisomerases.

Giaccone G. Giaccone G. Anticancer Res. 1994 Jan-Feb;14(1B):269-76. Anticancer Res. 1994. PMID: 8166466 Review.

3

Gemcitabine and paclitaxel combinations in non-small cell lung cancer.

Dombernowsky P, Giaccone G, Sandler A, Schwartsmann G. Dombernowsky P, et al. Among authors: giaccone g. Semin Oncol. 1998 Aug;25(4 Suppl 9):44-50. Semin Oncol. 1998. PMID: 9728584 Review.

4

Clinical impact of novel treatment strategies.

Giaccone G. Giaccone G. Oncogene. 2002 Oct 7;21(45):6970-81. doi: 10.1038/sj.onc.1205565. Oncogene. 2002. PMID: 12362278 Review.

5

Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors.

Janmaat ML, Giaccone G. Janmaat ML, et al. Among authors: giaccone g. Oncologist. 2003;8(6):576-86. doi: 10.1634/theoncologist.8-6-576. Oncologist. 2003. PMID: 14657536 Free article. Review.

6

The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression.

Roz L, Andriani F, Ferreira CG, Giaccone G, Sozzi G. Roz L, et al. Among authors: giaccone g. Oncogene. 2004 Dec 2;23(56):9102-10. doi: 10.1038/sj.onc.1208142. Oncogene. 2004. PMID: 15489891

7

FANCD2 expression in advanced non-small-cell lung cancer and response to platinum-based chemotherapy.

Ferrer M, Span SW, Vischioni B, Oudejans JJ, van Diest PJ, de Winter JP, Giaccone G, Kruyt FA. Ferrer M, et al. Among authors: giaccone g. Clin Lung Cancer. 2005 Jan;6(4):250-4. doi: 10.3816/CLC.2005.n.005. Clin Lung Cancer. 2005. PMID: 15694018

8

Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancer.

Giaccone G. Giaccone G. J Clin Oncol. 2005 May 10;23(14):3235-42. doi: 10.1200/JCO.2005.08.409. J Clin Oncol. 2005. PMID: 15886311 Review.

9

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials.

Bell DW, Lynch TJ, Haserlat SM, Harris PL, Okimoto RA, Brannigan BW, Sgroi DC, Muir B, Riemenschneider MJ, Iacona RB, Krebs AD, Johnson DH, Giaccone G, Herbst RS, Manegold C, Fukuoka M, Kris MG, Baselga J, Ochs JS, Haber DA. Bell DW, et al. Among authors: giaccone g. J Clin Oncol. 2005 Nov 1;23(31):8081-92. doi: 10.1200/JCO.2005.02.7078. Epub 2005 Oct 3. J Clin Oncol. 2005. PMID: 16204011 Clinical Trial.

10

EGFR inhibitors in lung cancer.

Buter J, Giaccone G. Buter J, et al. Among authors: giaccone g. Oncology (Williston Park). 2005 Nov;19(13):1707-11; discussion 1711-2, 1720-3. Oncology (Williston Park). 2005. PMID: 16425523 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

984 results

Search Page

Filters